Open AccessClinical Epidemiology and Management of Hidradenitis Suppurativa
Author(s) -
Christopher Sayed,
Jennifer L. Hsiao,
Martin Okun
Publication year - 2021
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000004321
Subject(s) - hidradenitis suppurativa , medicine , inframammary fold , dermatology , disease , groin , genodermatosis , scars , isotretinoin , surgery , pathology , acne , biochemistry , chemistry , implant , gene
Hidradenitis suppurativa is a chronic immune-mediated inflammatory skin disease with a prevalence of 0.1-1%, characterized by nodules and abscesses in the axillae, groin, and inframammary areas, sometimes developing into tunnels (or fistulas) and scars. Because hidradenitis suppurativa is more common in women and in those aged 18-40 years, obstetrician-gynecologists (ob-gyns) have the opportunity to diagnose, educate, initiate treatment, and coordinate care with ancillary health care professionals. The recently published North American treatment guidelines, along with management information for patients with hidradenitis suppurativa who are pregnant or breastfeeding, are summarized. By diagnosing and optimizing hidradenitis suppurativa treatment early in the disease course, ob-gyns can reduce morbidity, with the potential to favorably alter disease trajectory.